Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
| ID | Título | Última Revisión | Siguiente Revisión | Descripción | Acceso |
|---|---|---|---|---|---|
| 11.001.007 | Identification Of Microorganisms Using Nucleic Acid Probes | Jul 16, 2024 | Jul 20, 2025 | Nucleic acid probes are available for the identification of a wide variety of microorganisms. nucleic acid... | Ver |
| 11.001.009 | Noninvasine Techniques For The Evaluation And Monitoring Of Patients With Chronic Liver Disease | Dec 12, 2024 | Dec 20, 2025 | Noninvasive techniques to monitor liver fibrosis are being investigated as alternatives to liver biopsy in... | Ver |
| 11.001.010 | Alfa-fetoproteina en la deteccion de cancer hepatocelular | May 12, 2016 | Policy Archived | ... | Ver |
| 11.001.011 | Serum Biomarker Human Epididymis Protein 4 | Jan 21, 2025 | Jan 20, 2026 | Human epididymis protein 4 (he4) is a novel biomarker that has been cleared by the u.s. food and drug... | Ver |
| 11.001.012 | Jak2 And Mpl, Testing For Myeloproliferative Neoplasms | Sep 23, 2024 | Sep 20, 2025 | Somatic (acquired) genetic variants in jak2, mpl, and calr genes have been implicated as the underlying... | Ver |
| 11.001.013 | Urinary Biomarkers For Cancer Screening, Diagnosis, And Surveillance | Jan 21, 2025 | Jan 20, 2026 | The diagnosis of bladder cancer is generally made by cystoscopy and biopsy. bladder cancer has a very high... | Ver |
| 11.001.016 | Serum Biomarker Tests For Multiple Sclerosis | Jun 08, 2020 | Policy Archived | Serum antibodies to polysaccharide-containing molecules, called glycans, and other serum biomarkers are... | Ver |
| 11.001.017 | Pharmacogenetic Testing For Pain Management | Feb 20, 2025 | Feb 20, 2026 | While multiple pharmacologic therapies are available for the management of acute and chronic pain, there is a... | Ver |
| 11.001.018 | Diagnóstico serológico de la enfermedad celiaca | Sep 21, 2016 | Policy Archived | ... | Ver |
| 11.001.020 | Detection Of Circulating Tumor Cells In The Management Of Patients With Cancer | May 30, 2019 | Policy Archived | The prognosis of cancer patients is often determined by the occurrence of metastatic disease. studies have... | Ver |
| 11.001.021 | Measurement Of Long-Chain Omega-3 Fatty Acids In Red Blood Cell Membranes As A Cardiac Risk Factor | May 22, 2019 | Policy Archived | Epidemiologic studies have reported that subjects who eat a diet high in fish have a reduced risk of sudden... | Ver |
| 11.001.022 | Homocysteine Testing In The Screening, Diagnosis, And Management Of Cardiovascular Disease And Venous Thromboembolic Disease | Jan 08, 2025 | Jan 20, 2026 | Homocysteine is an amino acid that has been evaluated as a potential marker of cardiovascular disease (cvd)... | Ver |
| 11.001.023 | Procalcitonin As A Marker In The Systemic Inflammatory Response | Nov 10, 2021 | Policy Archived | Severe infection and sepsis are frequent causes of morbidity and mortality in intensive care units. infection... | Ver |
| 11.001.024 | Laboratory Testing For Hiv Tropism | Jan 19, 2021 | Policy Archived | Hiv tropism testing can determine the predominant coreceptor protein used by hiv to infect target cells.... | Ver |
| 11.001.026 | Genotipo y Fenotipo en HIV | May 16, 2016 | Policy Archived | ... | Ver |
| 11.001.027 | Immune Cell Function Assay | Jan 08, 2025 | Jan 20, 2026 | Careful monitoring of lifelong immunosuppression is required to ensure the long-term viability of solid organ... | Ver |
| 11.001.029 | Prueba fibronectina fetal | May 16, 2016 | Policy Archived | ... | Ver |
| 11.001.032 | Evaluation of Biomarkers for Alzheimer Disease | Jun 16, 2025 | Nov 20, 2025 | Biochemical changes associated with the pathophysiology of alzheimer disease (ad) are being evaluated to aid... | Ver |
| 11.001.033 | Bone Turnover Markers For The Diagnosis And Management Of Osteoporosis And Diseases Associated With High Bone Turnover | Feb 05, 2025 | Feb 20, 2026 | Bone turnover markers are biochemical markers of either bone formation or bone resorption. commercially... | Ver |
| 11.001.034 | Fecal Analysis In The Diagnosis Of Intestinal Dysbiosis | Jan 08, 2025 | Jan 20, 2026 | Intestinal dysbiosis may be defined as a state of disordered microbial ecology that is believed to cause... | Ver |
